thymopentin has been researched along with Innate Inflammatory Response in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Y; Li, X; Liu, T; Liu, Y; Peng, SJ; Wang, XX; Wang, Y; Wu, YC; Zhou, BT | 1 |
| Ahmad, B; Guo, H; Hou, Y; Koci, M; Si, D; Wei, X; Zhang, L; Zhang, R | 1 |
2 other study(ies) available for thymopentin and Innate Inflammatory Response
| Article | Year |
|---|---|
Thymopentin (TP-5) prevents lipopolysaccharide-induced neuroinflammation and dopaminergic neuron injury by inhibiting the NF-κB/NLRP3 signaling pathway.
Topics: Animals; Cell Line; Dopaminergic Neurons; Inflammation; Lipopolysaccharides; Mice; Microglia; Neuroinflammatory Diseases; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Signal Transduction; Thymopentin | 2023 |
C-Terminal Amination of a Cationic Anti-Inflammatory Peptide Improves Bioavailability and Inhibitory Activity Against LPS-Induced Inflammation.
Topics: Amination; Animals; Anti-Inflammatory Agents; Biological Availability; Cathelicidins; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Recombinant Proteins; Thymopentin | 2020 |